Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Tamai

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Antimicrobial Agents and Chemotherapy|February 1, 1988
Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranesA Tsuji, H Sato, Y Kume, et al.
FEBS Letters|January 13, 1998
Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1I Tamai, H Yabuuchi, J Nezu, et al.
Biochemical and Biophysical Research Communications|June 30, 2000
Molecular identification and characterization of novel members of the human organic anion transporter (OATP) familyI Tamai, J Nezu, H Uchino, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
Faropenem transport across the renal epithelial luminal membrane via inorganic phosphate transporter Npt1H Uchino, I Tamai, H Yabuuchi, et al.
The Journal of Pharmacy and Pharmacology|May 24, 2001
Active intestinal secretion of new quinolone antimicrobials and the partial contribution of P-glycoproteinK Naruhashi, I Tamai, N Inoue, et al.
Biochemical and Biophysical Research Communications|September 14, 1995
Participation of a proton-cotransporter, MCT1, in the intestinal transport of monocarboxylic acidsI Tamai, H Takanaga, H Maeda, et al.
The Journal of Pharmacy and Pharmacology|January 1, 1997
Intestinal brush-border membrane transport of monocarboxylic acids mediated by proton-coupled transport and anion antiport mechanismsI Tamai, H Takanaga, H Maeda, et al.
Journal of Pharmaceutical Sciences|April 3, 1999
Improvement of L-dopa absorption by dipeptidyl derivation, utilizing peptide transporter PepT1I Tamai, T Nakanishi, H Nakahara, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1990
Physiologically based pharmacokinetics of a new penem, SUN5555, for evaluation of in vivo efficacyA Tsuji, H Sato, I Tamai, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cationsH Yabuuchi, I Tamai, J Nezu, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Antimicrobial Agents and Chemotherapy|February 1, 1988
Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranesA Tsuji, H Sato, Y Kume, et al.
FEBS Letters|January 13, 1998
Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1I Tamai, H Yabuuchi, J Nezu, et al.
Biochemical and Biophysical Research Communications|June 30, 2000
Molecular identification and characterization of novel members of the human organic anion transporter (OATP) familyI Tamai, J Nezu, H Uchino, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
Faropenem transport across the renal epithelial luminal membrane via inorganic phosphate transporter Npt1H Uchino, I Tamai, H Yabuuchi, et al.
The Journal of Pharmacy and Pharmacology|May 24, 2001
Active intestinal secretion of new quinolone antimicrobials and the partial contribution of P-glycoproteinK Naruhashi, I Tamai, N Inoue, et al.
Biochemical and Biophysical Research Communications|September 14, 1995
Participation of a proton-cotransporter, MCT1, in the intestinal transport of monocarboxylic acidsI Tamai, H Takanaga, H Maeda, et al.
The Journal of Pharmacy and Pharmacology|January 1, 1997
Intestinal brush-border membrane transport of monocarboxylic acids mediated by proton-coupled transport and anion antiport mechanismsI Tamai, H Takanaga, H Maeda, et al.
Journal of Pharmaceutical Sciences|April 3, 1999
Improvement of L-dopa absorption by dipeptidyl derivation, utilizing peptide transporter PepT1I Tamai, T Nakanishi, H Nakahara, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1990
Physiologically based pharmacokinetics of a new penem, SUN5555, for evaluation of in vivo efficacyA Tsuji, H Sato, I Tamai, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cationsH Yabuuchi, I Tamai, J Nezu, et al.
Pageof 13